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Abstract  
The Guanidinium catalysts 7a-e were prepared and applied to the phase transfer alkylation of 
glycinate Schiff’s base 8 in 21-86% ee in addition to the phase transfer epoxidation of the 
chalcones 10a-e in 85-94% ee. The pKa values of 7a-d were determined to be in the range 
13.2-13.9, which supports a standard phase transfer mechanism for these processes. The use 
of 7a and 7e as catalysts for the addition of nucleophiles in Michael addition reactions was 
investigated and both were found to be effective catalysts. A counterion effect was apparent 
in these reactions, however no enantiomeric enrichment of the adducts was observed.  
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Introduction  
 
The guanidine motif is ubiquitous in nature and the protonated guanidinium side chain of the 
amino acid, arginine, leads to key highly selective hydrogen-bonding and electrostatic 
interactions with carboxylate and phosphate anionic groups.1 Many applications of 
guanidines in synthesis2 are known and their use as Brønsted base catalysts have been 
reported.3 More recently applications of guanidines and protonated guanidines as either bases 
or hydrogen bond donors in bifunctional organic catalysis have also been reported.4 We have 
previously reported the application of C2 symmetric guanidinium salts in phase transfer 
catalysis, and in Michael additions, and report our findings in more detail.  
 
Preparation of guanidine catalysts 7a-d 
 
Previously5 we reported the synthesis of the tetracyclic C2-symmetric guanidines 7a-d by the 
conjugate addition of guanidine to the enones 3 and 6. These enones were prepared from 
either ethyl R-3-hydroxybutyrate 1 or (S)-malic acid 4 in 5 and 6 steps respectively. (Scheme 
1)  
 
 
Scheme 1 (a) i) CH3COCHPPh3, nBuLi, ii) CH2O. (b) i) guanidine/DMF, ii) HCl/MeOH, iii) NaBF4 (aq). 
 (c) i) guanidine/DMF, ii) HCl/MeOH. (d) As (c) then i) TBDMSCl, imidazole, DMF, ii) NaBF4 (aq). 
(e) As in (c) then i) TBDPSCl, imidazole, DMF ii) NaBF4 (aq). 
 
The key reaction in both of these syntheses is the conjugate addition of guanidine to 2 
equivalents of the enones 3 or 6, which proceeds in good yield and gives the products 7a and 
7b, respectively. In the case of the parent catalyst 7a, the conjugate addition product was 
easily purified by column chromatography and crystallization from ether/petrol. The 
hydroxyl substituted catalyst 7b was found to be very hygroscopic and was thus converted to 
the silyl-protected catalysts 7c and 7d in reasonable overall yield. Catalyst 7e was prepared 
by ion exchange of 7a with NaBPh4. 
 
Phase transfer alkylation and epoxidation reactions 
 
With the catalysts 7a-d  in hand, we were interested in the applications of these catalysts to 
phase transfer catalysis (PTC)6 and firstly investigated the benzylation of the glycinate 
Schiff's base 87 leading to the alkylated product 9. (Scheme 2, Table 1) 
 
 
Scheme 2: (a) Catalyst 7, (0.1 eq.), NaOH (2 M), BnBr (2 eqv), CH2Cl2, 16 h 0 ºC-rt 
 
Table 1 
Entry Catalyst 7 % Conv. eei 
1 7a >97% 86% (R) 
2 7b 15% 21% (R) 
3 7c 70% 65% (R) 
4 7d 80% 74% (R) 
i ± 3% 
 
From these results it was apparent that the catalyst 7a is the best catalyst for this 
transformation effecting nearly complete conversion of 8 to the desired product 9, which was 
obtained as the R-enantiomer in 86% ee. The catalyst 7b gave the worst results with very low 
conversion and low ee, which can be attributed to its poor solubility in the organic phase of 
the reaction. The silyl protected catalysts 7c and 7d gave a lower percentage conversion 
however, still gave the alkylated products as the R-enantiomer in good ee, 65% and 74% 
respectively. The conversion rates for 7c and 7d could be raised to quantitative by increasing 
the concentration of sodium hydroxide in the reaction, or by allowing the reaction to progress 
for longer, however, this did not increase the ee of the product. The catalysts 7a, 7c and 7d 
are tolerant to these reaction conditions, may be removed from the reaction mixtures during 
isolation and purification of the product and can then be recycled by repeating the 
fluoroborate ion exchange steps of their preparation (Schemes 1). Our results and the 
selectivities observed are in agreement with the reactions reported by Nagasawa using 
structurally similar pentacyclic guanidine catalysts.8 
We next focused on the application of 7a to the PTC epoxidation of chalcones 10a-e9 
(Scheme 3) and found it to be an excellent catalyst for this transformation. We initially 
investigated the epoxidation of chalcone 10a (R1 = R2 = Ph) with NaOCl and found that the 
catalyst was effective over a range of 0.1 to 0.025 equivalents and gave the chalcone epoxide 
11a in consistent ee and in high yields (Table 2, entries 1-3). We wished to see if changes in 
the counter-ion of the hypochlorite had any effect on the ee or effectiveness of the process 
and thus investigated the use of LiOCl and KOCl in the reaction (both generated by the 
addition of the corresponding alkali metal salt to TCCA10). In both cases the reaction was 
slower and generally needed 0.1 equivalents of 7a to effect complete conversion, however, 
the ees of the products were in accordance with those observed with NaOCl (entries 4 and 5). 
A reaction was also performed using TCCA/NaOH (entry 3), which was again 
correspondingly slower and required a higher catalyst loading, however, gave a comparable 
ee. The reason for the slower rate of reaction was unclear, and the method for the generation 
of the hypochlorite might be the cause. Following this, a series of chalcones 10b-e (entries 6-
9) were investigated and in general the ee’s were very good (85-94 %) however in the case of 
the chalcone 10e (entry 9), this substrate proved to be unreactive to these conditions and no 
epoxide formation was observed. Epoxidation of 10e under the conditions reported by Lygo9 
using catalysts 12a (entry 10) and 12b (entry 11) did give the desired epoxide, however, both 
the percentage yield and ee’s were poor in contract to other examples of this reaction. This 
result would suggest that the presence of electron donating groups on the aromatic ketone, are 
detrimental to the reaction when catalysed with 7a. 
 
 
 
 
Scheme 3: (a) 7a, 12a or 12b (0.1 - 0.025 eqv), MOCl (aq.), toluene,  
16 - 72 h 0ºC – rt. M = Li, Na, K; R1, R2: See table 2 
 
Table 2 
Entry 10 R1 R2 M/time Catalyst 11 Yield % ee % Rot 
1 10a Ph- Ph- Na 16h 7a (0.025 eqv) 11a 80 91 (−) 
2 10a Ph- Ph- Na 16h  7a (0.05 eqv) 11a 99 93 (−) 
3 10a Ph- Ph- Na 48h 7a (0.1 eqv) 11a 89 89 (−) 
4 10a Ph- Ph- K 24h 7a (0.1 eqv) 11a 73 90 (−) 
5 10a Ph- Ph- Li 72h 7a (0.1 eqv) 11a 84 92 (−) 
6 10b -C6H13 Ph- Na 16h  7a (0.05 eqv) 11b 70 91 (−) 
7 10c Ph- 4-(Cl)-Ph- Na 16h 7a (0.05 eqv) 11c 51 85 (−) 
8 10d 4-(Cl)-Ph- Ph- Na 16h 7a (0.05 eqv) 11d 97 94 (−) 
9 10e 4-(Cl)-Ph- 3,4-di(MeO)-Ph- Na 16h 7a (0.05 eqv) 11e 0% --- --- 
10 10e 4-(Cl)-Ph- 3,4-di(MeO)-Ph- Na 16h 12a (0.06 eqv) 11e 51 35 (+) 
11 10e 4-(Cl)-Ph- 3,4-di(MeO)-Ph- Na 16h 12b (0.05 eqv) 11e 36 57 (+) 
 
In order to probe the role of guanidinium salts 7a-e in this reaction, we were keen to 
investigate the pKas of these species. We thus determined the pKa values for the catalysts 7a-
d, the previously prepared guanidinium salt 1311 and the conjugate acids of simple 
tetrasubstituted guanidines 14 and 15 in DMSO using a spectrophotometric method.12 The 
pKa values for 7a-d and 13, 14 (Table 3) were all relatively similar in value in the range 13.0 
- 13.9. The pKa of the commercially available tetramethylguanidine 14 was calculated as 
13.04 and was also in full agreement with the literature value of 13.0 (determined in DMSO) 
albeit using a different method.14 As an internal calibration, the pKa of acetic acid was also 
calculated as 12.48 using the spectrophotometric method, which is in accordance with the 
literature value of 12.31.13 The small increases in pKas between catalysts 13 and 7a-d relative 
to tetramethylguanidine 14 would be expected due to the electron-donating nature of the 
pyran scaffold, which will stabilise the cationic guanidinium ion relative to the neutral 
conjugate base. As the changes in the R-substituents of 7a – 7d are relatively remote from the 
site of ionisation, it is not surprising that pKa changes are small in this series. All of the 
catalysts 7a-7d and 13 clearly push the indicator/guanidine equilibrium towards deprotonated 
indicator as higher absorbance values are observed than for tetramethylguanidine 14, which 
shows an increased basicity of the catalysts. In fact, absorbance values for 7a – 7c and 13 are 
close to the Amax value observed for fully deprotonated indicator (the anion of 2,4-
dinitrodiphenylamine). An alternative indicator with a pKa value between that of 2,4-
dinitrodiphenylamine (12.74) and 2-naphthol (17.1) in DMSO was not available to provide 
additional estimates of pKas in these cases.  One exception was higher pKa value of 16.1 for 
the conjugate acid of 1,5,7-triazabicyclo[4.4.0]dec-5-ene 15. This 2 pK unit difference of 
basicity is of interest in comparison to the catalysts 7a-d and suggests that the pyran rings 
have an effect on their basicity when compared to the simple guanidines 13 and 14.  
 
  
Scheme 4  
 
Table 3 pKa values in DMSO for Guanidinium Salts 7a-d and 13-15 
 
Entry Compound pKa 
1 7a 13.87± 0.05 
2 7b 13.91± 0.08 
3 7c 13.62± 0.06 
4 7d 13.20± 0.06 
5 13 13.69± 0.05 
6 14 13.04± 0.05 
7 15 16.14± 0.05 
8 Acetic acid  12.48± 0.06 
 
As the reactions described herein utilising catalysts 7a-d and 13 are in mixed biphasic 
systems utilising non-polar toluene or DCM (x-y%) and highly polar water (10-50%), the use 
of pKas measured in DMSO will be a reasonable reflection of the polarity of the solvent 
system.1 The Henderson-Hasselbalch equation (Equation 1) relates pH to the pKa and gives 
the ratio of the species in the acidic/basic forms. For the guanidinium species (7a-d and 13-
15) the pKas were all above 13, and as our reactions were carried out at a pHobs >12 (as 
determined by pH meter), the estimated levels of protonation in the guanidine/guanidinium 
equilibrium is > 92%. This result suggests that the guanidine salts 7a-e are acting as a phase 
transfer agent under our conditions, rather than as a base or nucleophile, and a standard 
mechanistic rationale can be invoked.  
 
 
Equation 1. The Henderson-Hasselbalch equation, relating pH to pKa. 
 
 
                                                
1 The determination of pKa values directly in mixed solvent, biphasic systems is challenging 
particularly with non-polar solvent components such as toluene and DCM. 
 
 
Michael reactions 
We next investigated the application of 7a-e as catalysts for the Michael3 reaction. We 
had initially investigated the application of the salt 7a as a catalyst in the conjugate addition 
of pyrrolidine 16 to unsaturated lactone 17 (Scheme 5) which was reported by Mendosa.15 
We observed an increase in rate of reaction for all the guanidine salts 7a-e. The parent 
catalyst 7a gave a 4.3 fold increase in reaction rate, whilst the TBDMS-catalyst 7c gave a 9.6 
fold increase in reaction rate. A further improvement was found when catalyst 7e was 
employed, in which the BF4- counter-ion has been exchanged for the more bulky BPh4-, 
which led to a 16.3-fold increase in reaction rate over the uncatalyzed process. The effect of 
the BPh4- counterion in this process is that it is less co-ordinating and has a decreased 
hydrogen bonding interaction with the guanidine, thus allowing an easier formation of the 
proposed intermediate 19. Interesting the TBDPS-catalyst 7d gave very little increase in rate 
possibly showing that there is an inter-play between steric bulk and lipophilicity. 
Disappointingly no asymmetric induction was observed in this reaction which was attributed 
to the site of reaction being too far removed from the point of asymmetric induction within 
the proposed intermediate 19. 
 
  
 
Scheme 5 (a) 7a-e (0.1 eq.), 0.3 M in CDCl3 (i. 20% CD3OD was added) rt.  
 
We also studied the reaction of 2-hydroxy-1,4-napthaquinone 20 (lawsone) with 
trans-β-nitrostyrene 21 as it was known that this reaction could be catalysed using a 
bifunctional thiophosphoramide system.3w,x We initially investigated the background reaction 
of 20 with 21 in various solvents (Scheme 6, Table 3) and found that the reaction did not 
occur at an appreciable rate in non-protic solutions such as THF (entry 1), however the 
reaction did slowly proceed in ethanol with a T1/2 of 509 h (entry 2). It was also observed that 
the addition of water to the reaction solvents did accelerate the reaction, for example the 
addition of water (3%) to ethanol gave a 7.8 fold increase in rate (entry 3). We then 
investigated the use of catalyst 7a in this reaction and found that in ethanol the reaction 
proceeded slowly with a T1/2 of 86 h (entry 4), whilst the use of catalyst 7e (entry 5) with a 
bulkier counterion (BPh4-) gave a shorter T1/2 at 39 h (entry 5). Switching to the non-protic 
solvent THF led to the complete cessation of reaction when 7a was employed as the catalyst 
(entry 6), whilst catalyst 7e (entry 7) gave a T1/2 of 465 h (entry 7). The effect of the BPh4- 
counterion is again obvious in the increase in rate of reaction. This slower rate of reaction in 
THF suggested that the reaction might require a proton source we thought that the inclusion 
of an acid donor might accelerate the reaction and we attempted the reaction in the presence 
of L-proline. L-proline itself was a weak catalyst for the reaction with a T1/2 of 579 h in 
THF(entry 8) and in combination with 7a the reaction did proceed at a faster rate with a T1/2 
of 387 h (entry 9). Switching again to the catalyst 7e with the BPh4- counterion again had a 
positive effect with the rates of reaction in the non protic solvents acetonitrile, 
dichloromethane and THF having T1/2 values in the range of 80-100 h (entries 11-13). The 
best result observed using 7e at a higher concentration in THF with a T1/2 of 49 h and an 
overall yield of 95% after 8.5 days (entry 15). We attempted the use of N-methyl-L-proline 
which the slightly more basic N-Me group and found that this again worked as a catalyst with 
a T1/2 of 80 h (entry 16). comment 
 
Scheme 5 (a) 7a or 7e (0.05 eqv.), see table 3. 
 
Table 3 
Entry Solvent Catalyst Additive T1/2  
h (d)  
Conversion  
% (d) 
Yield % 
1 THF None None --- <1 (71) --- 
2 EtOH None None 509 (21) 75 (58) --- 
3 EtOH None H2O (3 %) 65 (2.7) 100 (30) 90 
4 EtOH 7a   None 86 (3.6) 90 (42) 76 
5 EtOH 7e None 39 (1.6) 100 (20) 82 
6 THF 7a None --- 0 (21)  --- 
7 THF 7e None 465 (19.4) 85 (71) 52 
9 THF None L-proline 579 (24.1)i  45 (22) 39 
10 THF 7a L-proline 387 (16.1)i 46 (14) 38 
11 CH3CN 7e  L-proline 100 (4.2) 94 (28) 92 
12 CH2Cl2 7e L-proline 84 (3.5) 95 (6)  85 
13 THF 7e  L-proline 80 (3.3) 97 (27) 77 
14 THF 2ii  7e L-proline 49 (2) 99 (8.5) 95 
15 THF 2ii 7e N-Methyl L-proline 80 (3.3) 70 (4.9) 65 
 
         i Estimated values. ii Triple concentration with respects to entry 13 
 
Conclusion 
Using a spectrophotometric method, pKa values in the range 13.2-13.9 in DMSO have been 
determined for a range of chiral guanidine-derived catalysts highlighting an increase in 
basicity relative to achiral tetramethylguanidine (pKa = 13.0). As these pKa values are 
substantially above the observed pH values (~12) for the synthetic applications of these 
catalysts in biphasic media described herein, a mechanism involving the protonated 
guanidinium ion as a phase transfer catalyst is most likely. 
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Experimental 
General conditions Column chromatography was carried out on silica gel (particle size 40 to 
63µm) and TLCs were conducted on precoated Kieselgel 60 F254 (Art. 5554; Merck) with 
the eluent specified in each case. All non-aqueous reactions were conducted in oven-dried 
apparatus under a static atmosphere of argon. Ether, THF and dichloromethane were dried on 
a Pure Solv MD-3 solvent purification system. Dry methanol and DMF was purchased from 
Aldrich. Chemical shifts are reported in δ values relative to chloroform (7.27/77.0 ppm) as an 
internal standard. Proton and carbon were recorded in CDCl3 on a Bruker AC250, AC400 or 
AC500 spectrometer unless otherwise stated. Mass spectra data were obtained at the EPSRC 
Mass Spectrometry Service Centre at the University of Wales, Swansea. Infrared spectra 
were recorded as thin films (oils) on a Bruker Tensor 27 series instrument. 
(R)-7-oxo-((tert-butyldimethylsilyl)oxy)oct-1-ene-3-one 3 
 
 
 
Acetylmethylene triphenylphosphorane (8.26 g, 28.9 mmol) was dissolved in dry THF (140 
mL), cooled (–78 ºC) whereupon BuLi (2.2 M, 11.9 mL, 26.3 mmol) was added drop wise 
over 5 min. The deep red solution that formed was then stirred at –60 ºC for 1 h. The reaction 
was cooled (–78 ºC) and (R)-3-((tert-butyldimethylsilyl)oxy)-1-iodobutane16 (8.26 g, 26.3 
mmol) in THF (42 mL) was added and the reaction warmed to rt by removal of the cooling 
bath followed by stirring overnight. Water (90 mL) was added and the solution was separated 
and the aqueous fraction extracted with dichloromethane (3 × 50 mL), the combined extracts 
dried (MgSO4) and concentrated by rotary evaporation to approximately 50 mL. 
Formaldehyde solution was then prepared by adding aqueous formaldehyde (94 mL) to 
dichloromethane (100 mL) and removing the water by drying (MgSO4). This dried solution 
was added to the reaction via a funnel containing a cotton wool plug and stirred overnight. 
The reaction was diluted with ether (100 mL) and washed with water (2 × 50 mL), then dried 
(MgSO4) and the solvent removed by rotary evaporation. Purification by column 
chromatography (4 % diethyl ether in petrol) gave 3 as a clear oil (5.34 g, 79%). Rf 0.19 (2% 
ethyl acetate/petrol); [α]D25 ˗13.4 (c 1.1 in CHCl3); δH 6.36 (1H, dd, J 17.6, 10.1 Hz, CH), 
6.21 (1H, dd, J 17.6, 1.5 Hz, CH), 5.81 (1H, dd, J 10.1, 1.5 Hz, CH), 3.79 (1H, apparent 
sextet, J 6.0 Hz, CH), 2.57 (2H, t, J 7.3 Hz, CH2), 1.37 - 1.73 (4H, m, 2 × CH2), 1.14 (3H, d, 
J 6.1 Hz, CH3), 0.88 (9H, s, 3 × CH3), 0.05 (6H, s, 2 × CH3); δC 200.8, 136.5, 127.9, 68.3, 
39.7, 39.1, 25.9, 23.7, 20.2, 18.1, ˗4.4, ˗4.8; νmax (neat) 2940 (C-H), 1684 (C=O), 1616 
(C=C); m/z (CI) 257 (5% [M+H]+), 201 (45% [MH˗tBu]+), 132 (50%), 74 (100%); HRMS 
(CI) found 257.1937 ([M+H]+), C14H29O2Si requires 257.1931. 
 
(6R, 6"R, 2R, 2"R)-6,6"-dimethyldispiro[tetrahydropyran-2,2'-(2,3,4,6,7,8- hexahydro-1H- 
pyrimido[1,2-a]pyrimidine)-8',2"-tetrahydropyran]-9'-ium tetrafluroborate 7a 
 
Enone 3 (1.99 g, 7.77 mmol) was dissolved in dry DMF (35 mL), cooled (0 ºC) and a 
solution of guanidine (0.23 g, 3.89 mmol) in DMF (5 ml) was added drop wise over 5 min. 
After stirring to rt over 16 h, the reaction was cooled (0 ºC) and methanolic HCl (40 mL, 
prepared by the slow addition of acetyl chloride (4 mL) to cooled (0 ºC) methanol (36 mL)) 
was added. The reaction was allowed to warm to rt and stirred vigorously for 3 h. After 
dilution with dichloromethane (200 mL) the mixture was washed LiBr solution (sat. 3 × 150 
mL) and water (3 × 100 mL). The aqueous washings were backwashed with dichloromethane 
(50 mL) and the combined organic washings were dried (MgSO4) and the solvent removed by 
rotary evaporation until approximately 30 mL of solution remained. An aqueous solution of 
NaBF4 (sat. 30 mL) was added and the mixture stirred overnight. After separation the organic 
phase was washed with water (3 × 30 mL), dried (MgSO4) and the solvent removed by rotary 
evaporation. Purification by column chromatography (gradient elution: chloroform to 1.5% 
methanol/chloroform 0.25 % steps) gave 7a (670 mg, 44 %) as a white solid after trituration 
with diethyl ether. Rf 0.39 (5% MeOH/CHCl3); [α]D25 +45 (c 0.65 in CHCl3); m.p. 181-
182oC; δH 7.50 (2H, br s, 2 × NH), 3.84 (2H, ddq, J 11.8, 6.1, 2.1 Hz, 2 × CH), 3.68 (2H, 
apparent dt, J 12.4, 5.0 Hz) 3.22 (2H, ddd, J 12.5, 5.8, 1.6 Hz), 1.50-2.20 (14H, m), 1.18 (2H, 
m, 2 × CH), 1.11 (6H, d, J 6.1 Hz, 2 × CH3); δC 148.4, 78.9, 66.9, 42.7, 33.6, 33.6, 32.1, 
21.7, 17.7; νmax 3378 (bm, NH str), 3004 (C-H), 1667 (C=N), 1599 (C=N); m/z (CI) 308 
(100% [M+H]+); HRMS (CI) found 308.2338. ([M+H]+) C17H30N3O2 requires 308.2333. 
 
(S)-6-(2,2-dimethyl-1,3-dioxolan-4-yl)hex-1-en-3-one 6 
 
 
Acetylmethylene triphenylphosphorane (2.73 g, 8.6 mmol) was dissolved in dry THF (40 
mL), cooled (–70 ºC) and BuLi (2.22 M, 3.87 mL, 8.6 mmol) was then added slowly over 15 
min. The reaction was then warmed and stirred for 1 h at –50 ºC then re-cooled (–78 ºC). 
(4S)-2,2-dimethyl-1,3-dioxolane-4-iodoethane5b (2.05 g, 7.81 mmol) was then added as a 
solution in THF (3 mL) and the reaction allowed to warm to rt over 12 h. Water (40 mL) was 
added and the mixture extracted with dichloromethane (3 × 20 mL). The organic layers were 
combined, dried (MgSO4) and the solvent removed by rotary evaporator. Formaldehyde in 
dichloromethane (prepared by drying (MgSO4) a mixture of aqueous formaldehyde (37 % 
w/v, 28 mL) and dichloromethane (30 mL)) was added and the reaction stirred for a further 
24 h. After washing with water (2 × 30 mL), the organic fraction was dried (MgSO4) and the 
solvent removed by rotary evaporator. The solid obtained was triturated with ether (5 × 30 
mL), and the resulting oil purified by column chromatography (5% diethyl ether/petrol) to 
yield the desired product as an unstable clear oil (1.08 g, 72%). Rf 0.19 (5% diethyl ether in 
petrol); δH 6.35 (1H, dd, J 17.7, 10.1 Hz), 6.20 (1H, dd, J 17.7, 1.6 Hz), 5.83 (1H, dd, J 1.6, 
10.1 Hz), 4.02-4.14 (2H, m, 2 × CH), 3.54 (1H, t, J 6.7 Hz), 2.65 (2H, t, J 7.0 Hz, CH2), 1.85-
1.52 (4H, m, 2 × CH2), 1.40 (3H, s, Me), 1.35 (3H, s, Me); δC 200.3, 136.5, 128.1, 108.8, 
75.8, 69.3, 32.9, 26.9, 25.7, 20.1; νmax (thin film) 2985 (C-H), 1701 (C=O), 1681 (C=C), 1369 
(C-H). 
(2R,6S,6''S,8'R)-6,6''-bis(hydroxymethyl)-3,3'',4,4',4'',5,5'',6,6',6'',7',9'-dodecahydro-1'H,3'H-
dispiro[pyran-2,2'-pyrimido[1,2-a]pyrimidine-8',2''-pyran]-5'-ium chloride 7b 
 
 
A solution of guanidine (68.0 mg, 1.2 mmol) in dry DMF (5 mL) was added to a cooled (0 
ºC) solution of enone 6 (0.5 g, 2.5 mmol) in dry DMF (2 mL) and the reaction warmed to rt 
over 24 h. The reaction was cooled (0 ºC) and methanolic HCl (7 mL, prepared from acetyl 
chloride (1 mL) and dry methanol (6 mL)) was then added and the reaction stirred for a 
further 3 h. After evaporation, column chromatography (graduated solvent system 0%, 1%, 
3%, 5%, 10%, 15%, 20%, 40% MeOH in CHCl3) followed by collecting of the fractions 
eluting at 15-20 % gave 7b (0.23 g, 45 %) as a highly hygroscopic solid. Rf 0.17 (15% 
MeOH/CHCl3); [α]D25 + 28 (c 0.5, MeOH). δH 3.74-3.92 (4H, m, 2 × CH2), 3.52-3.63 (4H, 
m, 2 × CH2), 3.35-3.50 (2H, m, 2 × CH), 1.70-2.20 (14H, m), 1.35-1.55 (4H, m, 2 × CH2); δC 
151.2, 81.2, 74.0, 67.3, 44.6, 35.9, 34.7, 28.6, 20.1; m/z (CI) 340.2 (100% [M+H]+); 
HRMS(EI) found 340.2236, C17H30N3O4 ([M]+) requires 340.2236. 
 
(2R,6S,6''S,8'R)-6,6''-bis(((isopropyldimethylsilyl)oxy)methyl)-3,3'',4,4',4'',5,5'',6,6',6'',7',9'-
dodecahydro-1'H,3'H-dispiro[pyran-2,2'-pyrimido[1,2-a]pyrimidine-8',2''-pyran]-5'-ium 
tetrafluoroborate 7c and (2R,6S,6''S,8'R)-6,6''-bis(((tert-butyldiphenylsilyl)oxy)methyl)-
3,3'',4,4',4'',5,5'',6,6',6'',7',9'-dodecahydro-1'H,3'H-dispiro[pyran-2,2'-pyrimido[1,2-
a]pyrimidine-8',2''-pyran]-5'-ium fluoroborate 7d 
         
 
Guanidinium salt 7d: Guanidine (403.0 mg, 6.8 mmol) as a solution in DMF (5 mL) was 
added to a stirred and cooled (0 ºC) solution of enone 6 (2.84 g, 14.3 mmol) in dry DMF (64 
mL) and the mixture slowly warmed to rt over 24 h. Methanolic HCl (25 mL, prepared from 
the addition of acetyl chloride (5 mL) to cooled dry methanol (20 mL)) was added and the 
mixture stirred for a further 4 h. The solvent was removed under reduced pressure and the 
resulting oil purified by column chromatography (gradient elution in CHCl3 then 3%, 5%, 
10%, 15%, 20% and 50% MeOH in CHCl3) with the fraction eluted at 10% being collected. 
These fractions were then dissolved in dry DMF (20 mL), cooled (0oC) and TBDMSCl (3.1 
g, 20.6 mmol) and imidazole (1.87 g, 27.5 mmol) added. After stirring to rt over 24 h the 
reaction was diluted with dichloromethane (100 mL) and washed with water (5 × 30 mL), 
LiBr solution (aq. sat., 30 mL) and water (30 mL) then dried (MgSO4). The organic phase 
was evaporated to ca. 30 mL and a solution of NaBF4 (sat., 30 mL) added and the mixture 
stirred for 16 h. The organic phase was separated, washed with water (3 × 30 mL), dried 
(MgSO4) and the solvent removed by rotary evaporation. Purification by column 
chromatography (gradient elution in CHCl3 then 0.5%, 1%, 2%, 5%, 10% and 20% MeOH in 
CHCl3) collecting the fractions eluting in 1-5 % MeOH in CHCl3 gave 7c (1.31 g, 29 %) as 
an amorphous white solid. 7c Rf = 0.35 (4% MeOH in CHCl3); [α]D25 + 47 (c 0.5 in CHCl3); 
m.p. 207-209 ºC; δH 7.45 (2H, br s, NH), 3.85-3.66 (4H, m, 2 × CH2), 3.51 (4H, d, J 5.0 Hz, 
2 × CH2), 3.18 (2H, dd, J 12.3, 5.2 Hz, 2 × CH), 1.54-2.00 (14H, m) 1.19-1.34 (2H, m, 2 × 
CHH), 0.85 (18H, s, 6 × CH3), -0.03 (12H, s, 4 × CH3); δC 148.5, 80.6, 78.9, 71.8, 66.3, 44.9, 
33.8, 33.0, 26.2, 25.8, 18.2, 17.1, -5.3; νmax (CHCl3) 3370 (N-H), 2953 (C-H), 1660 (N-H) 
cm-1; HRMS(EI) found 567.3876, C29H57N3O4Si2 ([M]+) requires 567.3888. 
Guanidinium salt 7d: This was prepared in an identical manner from enone 6 (2.97 g, 15.0 
mmol), guanidine (400.0 mg, 6.8 mmol), TBDPSCl (5.61 g, 20.4 mmol) and imidazole (1.87 
g, 27.2 mmol). Purification by column chromatography (gradient elution in CHCl3 then 2%, 
3%, 4%, 5%, 10%, 15% and 20% MeOH in CHCl3) collecting the fractions eluted at 4-5 % 
MeOH in CHCl3 gave 7d (2.21 g, 36 %) as an amorphous white solid. 7d Rf = 0.29 (4% 
MeOH in CHCl3); [α]25 + 44 (c 0.5 in CHCl3); m.p. 200 oC; δH 9.48 (2H, br s, NH), 7.71-
7.64 (8H, m, 8 x CH), 7.44-7.34 (12H, m, 12 x CH), 3.94-4.05 (2H, m, 2 × CH), 3.69-3.53 
(6H, m, 2 × CH2, 2 x CH), 3.02 (2H, dd, J 5.3, 11.7 Hz, 2 × CH), 2.65-2.41 (2H, m), 1.97-
1.50 (12H, m, 6 × CH2), 1.40-1.15 (2H, m), 1.02 (18H, s, 2 × tBu); δC 148.3, 135.4, 135.4, 
133.5, 133.4, 129.6, 129.5, 127.5, 78.7, 71.6, 66.7, 42.7, 33.5, 32.8, 26.0, 26.0, 19.1, 17.0; 
νmax (in CHCl3) 3360 (N-H), 2947 (C-H), 1664 (N-H); HRMS(EI) found 816.4583, 
C49H66N3O4Si2  ([M+H]+) requires 816.4592. 
 
(6R, 6"R, 2R, 2"R)-6,6"-Dimethyldispiro [tetrahydropyran-2,2'-(2,3,4,6,7,8-hexahydro-1H- 
pyrimido[1,2-a] pyrimidine)-8',2"-tetrahydropyran]-9'-ium tetraphenylborate 7e 
 
 
 
The reaction for the preparation of 7a was repeated with the omission of the final wash with 
NaBF4 solution. Purification of the residue obtained by column chromatography gave the 
corresponding guanidinium chloride (199.7 mg, 0.581 mmols) which was dissolved in dry 
THF (5 mL) and NaBPh4 (0.6 g, 1.75 mmols) was added. After stirring this mixture for 6 h, 
the solvent was removed in vacuo and the white solid obtained dissolved in dichloromethane 
(20 mL) and washed with H2O (2 × 50 mL) to remove NaCl and excess NaBPh4. The solution 
was dried (MgSO4), filtered and the solvent removed in vacuo to give 7e as a white solid 
(321.8 mg, 0.513 mmols) in 88 % yield. [α]27 + 67 (c 0.5 in CHCl3); m.p. 63-65 ºC (dec.); δH  
7.48 - 7.54 (8H, m, 8 × ArH), 7.07 (8H, app t, J 7.4 Hz, 8 × ArH), 6.93 (4H, t, J 7.2 Hz, 4 × 
ArH), 6.31 (2H, br s, 2 × NH), 3.41 - 3.52 (4H, m, 4 × CH), 2.92 (2H, dd, J 12.4, 5.5 Hz, 2 × 
CH), 1.78 (2H, dd, J 13.5, 4.3 Hz, 2 × CH), 1.26 - 1.58 (14H, m), 1.11 (6H, d, J 6.1 Hz, 2 × 
CH3); δC 164.7, 164.4, 164.0, 163.6, 148.0, 136.0, 125.8, 121.9, 79.0, 67.0, 42.7, 33.3, 32.8, 
32.0, 21.7, 18.0; δB -6.46. HRMS (CI) found 308.2332. ([M+H]+) C17H30N3O2 requires 
308.2333; found 319.1660 ([M]-) C24H20B requires 319.1664. 
 
General method for glycinate Schiff's base reactions 
The guanidinium salt 7a-e (0.04 mmol) and the glycinate Schiff's base 8 (120 mg, 0.407 
mmol) were dissolved in dichloromethane (2 mL) and aqueous NaOH solution (2 mL, 2M), 
was added. This mixture was cooled (0 ºC), vigorously stirred and BnBr (139 mg, 0.814 
mmol, 120 µL) was then added in one portion. After stirring to rt over 16 h, dichloromethane 
(15 mL) was added and the organic layer separated, dried (MgSO4) and evaporated, then 
purified by column chromatography (diethyl ether/petrol). Conversion rates were determined 
by 1H nmr and ee’s (+/- 3%) were determined on a Bakerbond DNPG column (98.5:1.5 
hexane:dioxane). 
 
General method for phase transfer epoxidation of chalcones 10a-e  
Using Sodium hypochlorite solution: The guanidinium salt 7a-e (0.025-0.10 eqv.) and the 
chalcone 10a-e (1.04-1.60 mmol) were dissolved in toluene (2-3 mL) and the mixture cooled 
(0 ºC) and stirred vigorously. Sodium hypochlorite solution (8% aqueous solution, 3 eqv.) 
was then added and the reaction stirred to rt over 16 h. Dichloromethane (15 mL) was added 
and the organic layer separated, dried (MgSO4) and evaporated. Purification by 
chromatography eluting with diethyl ether and petrol gave 11a-e. Enantiomeric excesses (+/- 
3%) were determined on a Chiralpak AD column (see supporting information). 
 
Using TCCA/MOH: Chalcone 10a (100 mg, 0.48 mmol) and the catalyst 7a (18.8 mg, 0.048 
mmol, 0.1 eqv) were dissolved in toluene (3 mL) and cooled (0 ºC). TCCA (74.5 mg, 0.32 
mmol, 0.67 eqv.) was then added ensuring full dissolution. If full dissolution did not occur 
additional toluene (1-2 mL) was added. The required alkali metal hydroxide solution (KOH 
(18 M, 0.27 mL), NaOH (18 M, 0.27 mL) or LiOH (5.1 M, 0.94 mL), 4.8 mmol, 15 eqv.) was 
added drop wise and the reaction was stirred vigorously for 24 h or until the reaction had 
reached completion as determined by TLC. At this point ether (25 mL) and water (25 mL) 
were added and the organic layer separated, the aqueous layer was extracted with further 
ether (2 × 25 mL) and the combined extracts dried (MgSO4) then passed through a short pad 
(ca. 2 cm) of silica gel eluting with further ether. After evaporation the resulting yellow oil 
was purified by column chromatography (0.5% diethyl ether in petrol to remove residual 
traces of chalcone then 1-3% in 0.5% increments) to give the chalcone epoxide 11a as a 
white solid. Enantiomeric excesses (+/- 3%) were determined on a Chiralpak AD column (see 
supporting information). 
 
General method for Michael addition of 2-hydroxy-1,4-napthaquinone 20 with trans-β-
nitrostyrene 21 2-Hydroxy-1,4-napthaquinone 20 (100 mg, 0.574 mmol) and trans-β-
nitrostyrene 21 (128.5 mg, 0.861 mmol, 1.5 eqv.) were dissolved in the required dry solvent 
(5-15 mL, see table 3) and the mixture cooled (0 °C). The catalyst 7a or 7e (0.05 eqv.) was 
added and the yellow reaction mixture allowed to warm to rt and stirred. The reaction was 
monitored by NMR and on completion the solvent was evaporated to give a deep red residue 
which was purified by column chromatography eluting firstly with 1-5% ethyl acetate in 
petrol to remove excess 21 then dichloromethane to give the product 22 as a yellow solid. In 
the cases where L-proline (0.05 eqv.) was added the catalyst was stirred with the L-proline for 
1h at rt, before cooling whereupon 20 and 21 were added sequentially as solids. Reaction 
progress was determined by sampling and determination by 1H nmr. For determination of 
enantiomeric excess (ee values), samples were analysed on a PerkinElmer Series 200 HPLC 
equipped with diode array detector monitoring at 254nm.  A 20ul injection of the sample 
dissolved in the mobile phase was separated using a CHIRALPAK IA column (250 x 4.6mm) 
with 90% Hexane with 0.1% TFA, 8% Ethanol and 2% Dichloromethane as the mobile phase 
(see supporting information). 
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